Zacks: Analysts Anticipate Healthpeak Properties, Inc. (NYSE:PEAK) Will Announce Earnings of $0.39 Per Share

Thursday, April 8, 2021 | MarketBeat

Equities analysts expect that Healthpeak Properties, Inc. (NYSE:PEAK) will report earnings per share (EPS) of $0.39 for the current quarter, according to Zacks Investment Research. Three analysts have made estimates for Healthpeak Properties' earnings, with the lowest EPS estimate coming in at $0.37 and the highest estimate coming in at $0.41. Healthpeak Properties reported earnings per share of $0.45 during the same quarter last year, which would suggest a negative year-over-year growth rate of 13.3%. The company is scheduled to report its next quarterly earnings report after the market closes on Tuesday, May 4th.

According to Zacks, analysts expect that Healthpeak Properties will report full year earnings of $1.58 per share for the current fiscal year, with EPS estimates ranging from $1.54 to $1.65. For the next year, analysts expect that the business will post earnings of $1.73 per share, with EPS estimates ranging from $1.66 to $1.85. Zacks Investment Research's earnings per share calculations are a mean average based on a survey of sell-side research firms that that provide coverage for Healthpeak Properties.

Healthpeak Properties (NYSE:PEAK) last issued its quarterly earnings results on Monday, February 8th. The company reported $0.27 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.23. Healthpeak Properties had a net margin of 13.46% and a return on equity of 4.19%.

Several research firms have recently weighed in on PEAK. Smith Barney Citigroup boosted their price objective on shares of Healthpeak Properties from $28.00 to $30.00 in a research note on Tuesday, December 15th. KeyCorp lowered shares of Healthpeak Properties from an "overweight" rating to a "sector weight" rating in a research note on Monday, December 14th. Capital One Financial upgraded shares of Healthpeak Properties from an "equal weight" rating to an "overweight" rating in a research note on Wednesday, January 20th. Bank of America upgraded shares of Healthpeak Properties from a "neutral" rating to a "buy" rating and boosted their price objective for the stock from $34.00 to $35.50 in a research note on Tuesday, March 30th. Finally, Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell boosted their price objective on shares of Healthpeak Properties from $28.00 to $30.00 in a research note on Tuesday, December 15th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and seven have issued a buy rating to the company's stock. Healthpeak Properties presently has an average rating of "Hold" and a consensus price target of $30.13.

Healthpeak Properties stock opened at $32.63 on Thursday. The firm has a market capitalization of $17.58 billion, a PE ratio of 54.38, a P/E/G ratio of 7.73 and a beta of 0.72. The company's 50-day moving average is $31.05 and its 200-day moving average is $30.24. Healthpeak Properties has a fifty-two week low of $20.56 and a fifty-two week high of $33.12. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.71 and a quick ratio of 0.71.

The business also recently announced a quarterly dividend, which was paid on Friday, March 5th. Investors of record on Monday, February 22nd were issued a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 3.68%. The ex-dividend date was Friday, February 19th. Healthpeak Properties's payout ratio is 68.18%.

Several hedge funds have recently made changes to their positions in PEAK. Acadian Asset Management LLC bought a new stake in Healthpeak Properties in the 3rd quarter valued at about $59,000. Federated Hermes Inc. boosted its holdings in Healthpeak Properties by 512.1% in the 3rd quarter. Federated Hermes Inc. now owns 4,866 shares of the company's stock valued at $132,000 after purchasing an additional 4,071 shares during the period. Morgan Stanley boosted its holdings in Healthpeak Properties by 5.3% in the 3rd quarter. Morgan Stanley now owns 2,624,563 shares of the company's stock valued at $71,259,000 after purchasing an additional 133,114 shares during the period. Nuveen Asset Management LLC boosted its holdings in Healthpeak Properties by 13.0% in the 3rd quarter. Nuveen Asset Management LLC now owns 7,113,596 shares of the company's stock valued at $193,134,000 after purchasing an additional 816,889 shares during the period. Finally, Lombard Odier Asset Management Europe Ltd bought a new stake in Healthpeak Properties in the 3rd quarter valued at about $221,000. 93.46% of the stock is owned by institutional investors and hedge funds.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns and develops high-quality real estate in the three private-pay healthcare asset classes of Life Science, Medical Office and Senior Housing, designed to provide stability through the inevitable industry cycles.

Read More: What are popular green investing opportunities?

Get a free copy of the Zacks research report on Healthpeak Properties (PEAK)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Healthpeak Properties (NYSE:PEAK)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Featured Article: What is operating income?



7 Stocks That Cathie Wood is Buying And You Should Too

If you’re an investor that likes to go with the “hot hand,” then they don’t get much hotter than Cathie Wood. The founder and CEO of ARK Investment Management delivered returns of over 100% in all five of her firm’s exchange-traded funds (ETFs) in 2020.

The names of her funds showcase some of the hottest emerging growth trends in the market: financial technology (fintech), genomic revolution, innovation, autonomous technology/robotics, and next generation internet.

As you would expect, these funds contain some of the hottest growth stocks from the past year. And in the aftermath of the tech selloff, Wood is not backing away. In fact, she’s doubling down on her strategy. It might not be exactly a matter of being greedy while others are fearful; perhaps more like being prepared while others are distracted.

But the other thing about Wood’s selections is that many of them are not obscure names. These are companies that were among the hottest names in 2020. Wood simply believes that they still have room to run. And that’s one reason you should consider making them a part of your portfolio.

In this special presentation, we’re giving you just seven of the stocks that Cathie Wood is buying or has bought recently. We’ve attempted to pick out at least one stock from each of the ARK ETFs. As with any investment decision, it’s important that you perform your own research before making a decision.

View the "7 Stocks That Cathie Wood is Buying And You Should Too".


MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.